FDA grants emergency use of convalescent plasma for COVID-19 patients
The US FDA issued emergency use authorization for convalescent plasma in treating COVID-19 patients, citing early evidence of potential benefit and high demand from healthcare providers. The decision followed days of public statements by President Trump alleging political delays in approval.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
NewsFDA grants emergency use of convalescent plasma for COVID-19 patients
Sign in or subscribeBrowse free archive reportsThe US FDA issued emergency use authorization for convalescent plasma in treating COVID-19 patients, citing early evidence of potential benefit and high demand from healthcare providers. The decision followed days of public statements by President Trump alleging political delays in approval.